QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
Europe - FRA:QIA - NL0015002CX3 - Common Stock
37.335 EUR
-0.02 (-0.05%)
We assign a fundamental rating of 7 out of 10 to QIA. QIA was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QIA a very profitable company, without any liquidiy or solvency issues. QIA is not valued too expensively and it also shows a decent growth rate. These ratings could make QIA a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
QIA had positive earnings in the past year.
QIA had a positive operating cash flow in the past year.
In the past 5 years QIA has always been profitable.
In the past 5 years QIA always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 6.41%, QIA is doing good in the industry, outperforming 77.78% of the companies in the same industry.
The Return On Equity of QIA (10.65%) is better than 66.67% of its industry peers.
With a decent Return On Invested Capital value of 8.66%, QIA is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QIA is in line with the industry average of 7.57%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(8.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROIC | 8.66% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
Looking at the Profit Margin, with a value of 18.30%, QIA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
QIA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 26.86%, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.18%, QIA belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QIA is creating some value.
QIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
Compared to 1 year ago, QIA has an improved debt to assets ratio.
2.2 Solvency
QIA has an Altman-Z score of 3.83. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.83, QIA is doing good in the industry, outperforming 66.67% of the companies in the same industry.
QIA has a debt to FCF ratio of 2.91. This is a good value and a sign of high solvency as QIA would need 2.91 years to pay back of all of its debts.
QIA's Debt to FCF ratio of 2.91 is amongst the best of the industry. QIA outperforms 83.33% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that QIA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.25, QIA belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Altman-Z | 3.83 |
ROIC/WACC1.16
WACC7.45%
2.3 Liquidity
A Current Ratio of 1.61 indicates that QIA should not have too much problems paying its short term obligations.
QIA has a Current ratio of 1.61. This is in the better half of the industry: QIA outperforms 77.78% of its industry peers.
QIA has a Quick Ratio of 1.35. This is a normal value and indicates that QIA is financially healthy and should not expect problems in meeting its short term obligations.
QIA has a better Quick ratio (1.35) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.20%, which is quite good.
Measured over the past years, QIA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.40% on average per year.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.15%.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
3.2 Future
QIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.78% yearly.
Based on estimates for the next years, QIA will show a small growth in Revenue. The Revenue will grow by 7.82% on average per year.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.78%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.82%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.39 indicates a rather expensive valuation of QIA.
Based on the Price/Earnings ratio, QIA is valued a bit cheaper than 72.22% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.83, QIA is valued a bit cheaper.
QIA is valuated correctly with a Price/Forward Earnings ratio of 16.59.
66.67% of the companies in the same industry are more expensive than QIA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 32.68. QIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.39 | ||
| Fwd PE | 16.59 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 66.67% of the companies listed in the same industry.
72.22% of the companies in the same industry are more expensive than QIA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.82 | ||
| EV/EBITDA | 13.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
QIA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)2.19
EPS Next 2Y8.08%
EPS Next 3Y8.5%
5. Dividend
5.1 Amount
With a yearly dividend of 0.54%, QIA is not a good candidate for dividend investing.
QIA's Dividend Yield is a higher than the industry average which is at 0.72.
Compared to an average S&P500 Dividend Yield of 2.39, QIA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
FRA:QIA (11/7/2025, 7:00:00 PM)
37.335
-0.02 (-0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.95%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.10B
Revenue(TTM)2.04B
Net Income(TTM)373.39M
Analysts74.17
Price Target44.7 (19.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.51%
EPS beat(12)8
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)5.44%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)0.23%
PT rev (3m)0.15%
EPS NQ rev (1m)-0.31%
EPS NQ rev (3m)0.3%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)1.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.39 | ||
| Fwd PE | 16.59 | ||
| P/S | 4.58 | ||
| P/FCF | 18.82 | ||
| P/OCF | 13.83 | ||
| P/B | 2.66 | ||
| P/tB | 14.6 | ||
| EV/EBITDA | 13.04 |
EPS(TTM)2.03
EY5.44%
EPS(NY)2.25
Fwd EY6.03%
FCF(TTM)1.98
FCFY5.31%
OCF(TTM)2.7
OCFY7.23%
SpS8.16
BVpS14.02
TBVpS2.56
PEG (NY)2.15
PEG (5Y)2.19
Graham Number25.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROCE | 11.67% | ||
| ROIC | 8.66% | ||
| ROICexc | 10.87% | ||
| ROICexgc | 46.44% | ||
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% | ||
| FCFM | 24.31% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 94.78% | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.61% | ||
| Profit Quality | 132.83% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 3.83 |
F-Score8
WACC7.45%
ROIC/WACC1.16
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.78%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.82%
EBIT growth 1Y21.82%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QIA.DE FAQ
What is the fundamental rating for QIA stock?
ChartMill assigns a fundamental rating of 7 / 10 to QIA.DE.
What is the valuation status of QIAGEN N.V. (QIA.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.
How profitable is QIAGEN N.V. (QIA.DE) stock?
QIAGEN N.V. (QIA.DE) has a profitability rating of 8 / 10.
What is the valuation of QIAGEN N.V. based on its PE and PB ratios?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 18.39 and the Price/Book (PB) ratio is 2.66.
How financially healthy is QIAGEN N.V.?
The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.